UnknownNot Applicable

Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia

South Korea45 participantsStarted 2016-09-05

Plain-language summary

This study is to investigate on the objective relevance between bispectral index (BIS) and Observer's assessment of alertness/sedation (OAA/S) scale in patients sedated with Midazolam, propofol and dexmedetomidine during spinal anesthesia. Also, we will evaluate the reflection of actual sedation levels on BIS monitoring.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who scheduled for knee arthroscopic surgery under spinal anesthesia Exclusion Criteria: * Patients with a history of hepatic, renal, cardiovascular disease, and those who have allergy to study drugs (dexmedetomidine, propofol, midazolam). * Hemodynamically unstable patients. * Patients who is noncommunicative.

What they're measuring

correlation between BIS and OAA/S (observer's assessment of alertness/sedation) score

Timeframe: 1 day

Trial details

NCT IDNCT03399019

SponsorHallym University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03-01

Contact for this trial

Yi Hwa Choi, M.D

+82-31-380-3945 pcyhchoi@hallym.or.kr

View on ClinicalTrials.gov More Sedation trials